Interoception: Neural Sensing and Control of Organ Function (A1)
January 10-13, 2028
| La Fonda on the Plaza, Santa Fe, NM, United States
Olujimi A Ajijola, Lauren L Orefice and Ivan E. de Araujo
| 4:00–8:00 PM |
Registration |
|
| 6:00–8:00 PM |
Welcome Mixer |
|
Tuesday, January 11, 2028
| 8:00–8:10 AM |
Welcome Remarks |
|
| 8:10–9:00 AM |
Keynote Address |
|
| |
Ardem Patapoutian †, The Scripps Research Institute
Molecular Sensors and Brain–Body Communication |
|
| 9:00–11:15 AM |
Technologies for Interrogating and Modulating Brain–Body Communication |
|
| |
Viviana Gradinaru †, California Institute of Technology
Mapping and Modulating Neural Circuits in Physiology and Disease |
|
| |
Polina Anikeeva †, Massachusetts Institute of Technology
Enabling Neurovisceral Mapping Using Novel Tools |
|
| |
John Rogers †, Northwestern University
Biocompatible Devices to Interrogate Brain-Body Communication |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:30–9:50 AM |
Coffee Break |
|
| 11:25–12:25 PM |
Panel Discussion: 1: Across the continuum: Funding and Publishing your Research in Interoception |
|
| 12:25–1:00 PM |
Poster Setup |
|
| 12:25–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 2:30–4:30 PM |
Symposia Spotlight 1: Leveraging Artificial Intelligence/Machine Learning/Novel Computational Approaches to Advance Interoception Research |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Neural Sensing of the Heart, Lung and Kidney |
|
| |
Olujimi A Ajijola, UCLA Cardiac Arrhythmia Center
Cardioception: Visceral Afferents and the DRG in Cardiac Homeostasis |
|
| |
Rose Z Hill †, Oregon Health & Science University
Neural Mechanisms Underlying Kidney-Brain Communication |
|
| |
Xin Sun †, University of California, San Diego
The Lung as a Sensory Organ Influencing Behavior |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
Wednesday, January 12, 2028
| 8:00–11:00 AM |
Gut–Brain and Visceral Sensory Pathways |
|
| |
Ivan E. de Araujo †, Max Planck Institute for Biological Cybernetics
Neural Mechanisms Linking Nutrient Sensing to Motivation |
|
| |
Nick J. Spencer †, Flinders University
Decoding the Enteric Nervous System |
|
| |
Chuchu Zhang †, University of California, Los Angeles
Sensing Toxic Agents and Neural Control of Nausea |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–1:00 PM |
Poster Setup |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 1:00–10:00 PM |
Poster Viewing |
|
| 3:00–4:30 PM |
Career Roundtable |
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–7:00 PM |
Neuroimmune Communication and Organ Sensing |
|
| |
Caroline Sokol †, Ragon Institute of Mass General Brigham, MIT, and Harvard
Nociceptive-Immune Mechanisms in Skin Sensing |
|
| |
Daniel Mucida †, Rockefeller University
The Microbes, the Gut, and the Brain: Finding Balance in the Intestine |
|
| |
Christopher Banek †, University of Minnesota
A Neuroimmune Bridge between the Kidney and Brain |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
Thursday, January 13, 2028
| 8:00–11:00 AM |
Ascending Pathways: Vagal, Spinal, and Brainstem Circuits |
|
| |
Vineet Augustine †, University of California, San Diego
Vagal Afferents and Cardiac Interoception |
|
| |
Lauren L Orefice, Massachusetts General Hospital / Harvard Medical School
Spinal Sensory Neuron Dysfunction in Neurodevelopmental Disorders |
|
| |
Sarah Stanley †, Icahn School of Medicine at Mount Sinai
Central-Peripheral Circuits Governing Glucose Control |
|
| |
Maya Kaelberer †, University of Arizona
Vagal Sensing and Feeding-Related Interoception |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 9:00–9:20 AM |
Coffee Break |
|
| 11:00–5:00 PM |
On Own for Lunch |
|
| 2:30–4:30 PM |
Symposia Spotlight 2: Interoception at the Bedside: Diagnostic and Therapeutic Interoception-Based Approaches |
|
| |
Short Talks Chosen from Abstracts
|
|
| 4:30–5:00 PM |
Coffee Available |
|
| 5:00–6:45 PM |
Advancing Interoception Science toward Clinical Therapeutics – Industry Perspective |
|
| |
Daniel M. Skovronsky †, Eli Lilly and Company
Targeting Interoceptive Mechanisms for Clinical Therapeutics |
|
| |
Holly Grammer †, LivaNova
Clinical Neuromodulation of Vagal Communication – Future Directions |
|
| |
Ashwini Sharan †, Medtronic
Interoceptive Signals as Control Variables for Closed Loop Neuromodulation |
|
| |
Kristoffer Famm †, Galvani Bioelectronics
Bioelectronic Medicine to Modulate Brain-Body Communication |
|
| |
Short Talk(s) Chosen from Abstracts
|
|
| 6:45–7:00 PM |
Meeting Wrap-Up: Outcomes and Future Directions |
|
| 7:00–8:00 PM |
Social Hour with Dinner |
|
| 8:00–11:00 PM |
Entertainment |
|
